Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.37B |
| 3 |
Invesco MSCI USA ETF
PBUS
|
+$1.52B |
| 4 |
Synopsys
SNPS
|
+$1.47B |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$1.26B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$2.63B |
| 2 |
Tesla
TSLA
|
+$2.46B |
| 3 |
Aon
AON
|
+$1.21B |
| 4 |
Oracle
ORCL
|
+$1.04B |
| 5 |
Apple
AAPL
|
+$925M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.08% |
| 2 | Financials | 11.07% |
| 3 | Consumer Discretionary | 8.45% |
| 4 | Communication Services | 7.49% |
| 5 | Healthcare | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPRX
2301
DELISTED
Catalyst Pharmaceutical
CPRX
| $36.3M | ﹤0.01% |
1,843,624
-1,339,899
| -42% | -$27.6M |
|
2302
Nuveen California AMT-Free Quality Municipal Income Fund
NKX
$666M
| $36.3M | ﹤0.01% |
2,863,725
+167,744
| +6% | +$2M |
|
|
CDTX
2303
DELISTED
Cidara Therapeutics
CDTX
| $36.2M | ﹤0.01% |
378,184
-505,231
| -57% | -$32.2M |
|
2304
iShares MSCI Italy ETF
EWI
$1.08B
| $36.1M | ﹤0.01% |
695,113
+39,806
| +6% | +$1.99M |
|
2305
Supernus Pharmaceuticals
SUPN
$2.74B
| $36.1M | ﹤0.01% |
755,317
+61,565
| +9% | +$2.48M |
|
|
PPLT
2306
abrdn Physical Platinum Shares ETF
PPLT
$2B
| $36.1M | ﹤0.01% |
2,525,770
+21,670
| +0.9% | +$274K |
|
2307
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$273M
| $36.1M | ﹤0.01% |
528,545
+31,023
| +6% | +$2.08M |
|
2308
Xtrackers MSCI EAFE High Dividend Yield Equity ETF
HDEF
$2.34B
| $36.1M | ﹤0.01% |
1,225,593
+443,690
| +57% | +$13M |
|
2309
Hawkins
HWKN
$2.67B
| $35.9M | ﹤0.01% |
196,720
-46,439
| -19% | -$7.76M |
|
|
BTX
2310
BlackRock Technology and Private Equity Term Trust
BTX
$1.06B
| $35.9M | ﹤0.01% |
5,364,223
-196,766
| -4% | -$1.41M |
|
2311
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$726M
| $35.9M | ﹤0.01% |
422,842
-43,423
| -9% | -$3.53M |
|
2312
Crane NXT
CXT
$2.96B
| $35.9M | ﹤0.01% |
535,679
-1,625
| -0.3% | -$96.8K |
|
2313
Payoneer
PAYO
$2.42B
| $35.9M | ﹤0.01% |
5,928,627
+568,587
| +11% | +$3.81M |
|
2314
iShares US Healthcare Providers ETF
IHF
$1.26B
| $35.8M | ﹤0.01% |
725,506
-128,639
| -15% | -$5.88M |
|
2315
Ramaco Resources Class A
METC
$667M
| $35.8M | ﹤0.01% |
1,079,523
+795,050
| +279% | +$18.5M |
|
2316
State Street SPDR S&P International Dividend ETF
DWX
$529M
| $35.8M | ﹤0.01% |
838,852
-14,080
| -2% | -$599K |
|
2317
FirstCash
FCFS
$9.14B
| $35.8M | ﹤0.01% |
225,962
-67,008
| -23% | -$9.37M |
|
2318
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.69B
| $35.8M | ﹤0.01% |
2,910,360
+206,994
| +8% | +$2.46M |
|
|
HIO
2319
Western Asset High Income Opportunity Fund
HIO
$338M
| $35.8M | ﹤0.01% |
9,312,131
+397,447
| +4% | +$1.58M |
|
2320
Burford Capital
BUR
$968M
| $35.7M | ﹤0.01% |
2,985,321
+370,542
| +14% | +$4.95M |
|
2321
Eldorado Gold
EGO
$10B
| $35.7M | ﹤0.01% |
1,235,420
-440,804
| -26% | -$10.4M |
|
2322
Franklin US Core Bond ETF
FLCB
$3.05B
| $35.6M | ﹤0.01% |
1,638,696
+141,043
| +9% | +$3.03M |
|
2323
Customers Bancorp
CUBI
$2.82B
| $35.6M | ﹤0.01% |
544,265
+63,798
| +13% | +$4.2M |
|
2324
Recursion Pharmaceuticals
RXRX
$1.78B
| $35.6M | ﹤0.01% |
7,290,353
+1,600,741
| +28% | +$8.41M |
|
2325
M/I Homes
MHO
$3.9B
| $35.6M | ﹤0.01% |
246,156
-63,261
| -20% | -$8.56M |
|
Similar funds
Morgan Stanley's Q3 2025 Portfolio in Review
As of Q3 2025, Morgan Stanley held 8,451 positions worth $1.65T, up 7.6% from $1.54T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q3 2025 filing shows 366 new, 3,476 increased, 3,384 reduced and 292 closed positions. Its largest new stake was Paramount Skydance Corp: 14,829,379 shares worth $281M. The largest sale was Alphabet (Google) Class A, an estimated $2.63B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q3 2025 buy was Paramount Skydance Corp: 14,829,379 shares worth $281M.
- Morgan Stanley added most to Invesco QQQ Trust in Q3 2025, an estimated $2.4B increase.
- Morgan Stanley's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $2.63B.
- Morgan Stanley fully exited Paramount Global Class B in Q3 2025, selling an estimated $521M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.65T portfolio in Q3 2025.
- Morgan Stanley opened 366 new positions and closed 292 in Q3 2025.
- Morgan Stanley's portfolio value rose 7.6% quarter-over-quarter to $1.65T.
Based on Morgan Stanley's 13F filing for Q3 2025, filed 14 Nov 2025.